Publicacións en colaboración con investigadores/as de University of Milan (14)

2013

  1. VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease

    Blood, Vol. 121, Núm. 12, pp. 2336-2339

2011

  1. A comparison between two semi-quantitative bleeding scales for the diagnosis and assessment of bleeding severity in type 1 von Willebrand disease

    Haemophilia

2010

  1. The impact of bleeding history, von willebrand factor and PFA-100® on the diagnosis of type 1 von willebrand disease: Results from the european study MCMDM-1VWD

    British Journal of Haematology, Vol. 151, Núm. 3, pp. 245-251

  2. Validation of a rapid test (VWF-LIA) for the quantitative determination of von Willebrand factor antigen in type 1 von Willebrand disease diagnosis within the European multicenter study MCMDM-1VWD

    Thrombosis Research, Vol. 126, Núm. 3, pp. 227-231

2009

  1. Expression of 14 von Willebrand factor mutations identified in patients with type.1 von Willebrand disease from the MCMDM-1VWD study

    Journal of Thrombosis and Haemostasis, Vol. 7, Núm. 8, pp. 1304-1312

2008

  1. Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)

    Journal of Thrombosis and Haemostasis, Vol. 6, Núm. 5, pp. 762-771

  2. Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the european study: Molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)

    Blood, Vol. 111, Núm. 10, pp. 4979-4985

  3. Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): Results from the European Study MCMDM-1VWD

    Blood, Vol. 111, Núm. 7, pp. 3531-3539

2007

  1. Impact of plasma von Willebrand factor levels in the diagnosis of type 1 von Willebrand disease: Results from a multicenter European study (MCMDM-1VWD)

    Journal of Thrombosis and Haemostasis, Vol. 5, Núm. 4, pp. 715-721

  2. Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)

    Blood, Vol. 109, Núm. 1, pp. 112-121

  3. von Willebrand factor/factor VIII concentrate (Haemate® P) dosing based on pharmacokinetics: A prospective multicenter trial in elective surgery

    Journal of Thrombosis and Haemostasis, Vol. 5, Núm. 7, pp. 1420-1430

2006

  1. A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: Results from a multicenter European study (MCMDM-1 VWD)

    Journal of Thrombosis and Haemostasis, Vol. 4, Núm. 4, pp. 766-773

  2. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD

    Journal of Thrombosis and Haemostasis, Vol. 4, Núm. 4, pp. 774-782

2005

  1. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: An international, multicenter study

    Journal of Thrombosis and Haemostasis, Vol. 3, Núm. 12, pp. 2619-2626